Q32 Bio (QTTB) Other Operating Expenses (2022)

Q32 Bio (QTTB) posted quarterly Other Operating Expenses of $131.2 million for Q1 2022.

Q32 Bio (QTTB) Other Operating Expenses (2022) Analysis & Trends

Q32 Bio's Other Operating Expenses history runs 1 years deep, the most recent figure standing at $131.2 million for Q1 2022.

In Q1 2022, Other Operating Expenses changed N/A year-over-year to $131.2 million; the TTM figure through Dec 2022 stood at $131.2 million (changed N/A YoY), while the FY2025 annual figure was $11.7 million, changed N/A from the prior year.
Other Operating Expenses for Q1 2022 stood at $131.2 million.
The five-year high for Other Operating Expenses was $131.2 million in Q1 2022, with the low at $131.2 million in Q1 2022.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn
4	Revolution Medicines	43.64 Bn	43.64 Bn	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn
7	Royalty Pharma	33.72 Bn	35.84 Bn	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn
10	Q32 Bio	359.61 Mn	253.31 Mn	-

Historic Data

Download Data

Date	Value
Mar 31, 2022	131.25 Mn